Drugs for Melanosis, Neurocutaneous (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 96)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Azelaic acid |
Approved |
Phase 4 |
|
123-99-9 |
2266 |
Synonyms:
1,7-Dicarboxyheptane
1,7-Heptanedicarboxylate
1,7-Heptanedicarboxylic acid
1,9-Nonanedioate
1,9-Nonanedioic acid
Acide azelaique
ACIDE AZÉLAÏQUE
ÁCIDO AZELAICO
ACIDUM ACELAICUM
Acidum azelaicum
alpha,omega-Nonanedioic acid
Anchoate
Anchoic acid
Azalaic acid
Azelaate
Azelaic acid
Azelaic acid, dilithium salt
Azelaic acid, dipotassium salt
Azelaic acid, disodium salt
Azelaic acid, monosodium salt
Azelaic acid, potassium salt
Azelaic acid, sodium salt
Azelaicacidtech
Azelainic acid
Azelainsaeure
AZELAINSÄURE
Azelate
|
Azelex
Azelic acid
Emerox 1110
Emerox 1144
Emery'S L-110
Finacea
Finevin
Heptanedicarboxylic acid
Lepargylate
Lepargylic acid
Monosodium azelate
N-Nonanedioate
N-Nonanedioic acid
Nonandisaeure
NONANDISÄURE
Nonanedioate
Nonanedioic acid
Nonanedioic acid azelaic acid
Nonanedioic acid homopolymer
NSC-19493
Poly(azelaic anhydride)
Polyazelaic anhydride
Skinorem
Skinoren
ZK-62498
α,ω-Nonanedioic acid
|
|
2 |
|
Ethanol |
Approved |
Phase 4 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
3 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
4 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 4 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
5 |
|
Salicylic acid |
Approved, Investigational, Vet_approved |
Phase 4 |
|
69-72-7 |
338 |
Synonyms:
2 Hydroxybenzoic acid
2-Carboxyphenol
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-HYDROXYBENZOate
2-HYDROXYBENZOIC ACID
Acid, 2-hydroxybenzoic
Acid, O-hydroxybenzoic
Acid, ortho-hydroxybenzoic
Acid, salicylic
ácido salicílico
Acidum salicylicum
Advanced pain relief callus removers
Advanced pain relief corn removers
Bazuka Extra Strength Gel®|salicylate
Clear away wart remover
Compound W
Dr. scholl's callus removers
Dr. scholl's corn removers
Dr. scholl's wart remover kit
Duofil wart remover
Duoplant
Freezone
Ionil
|
Ionil plus
K 537
K 557
O Hydroxybenzoic acid
O-Carboxyphenol
O-Hydroxybenzoate
O-Hydroxybenzoic acid
Ortho hydroxybenzoic acid
Ortho-hydroxybenzoic acid
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Psoriacid-S-stift
Retarder W
Rutranex
SA
Salicylate
Salicylic acid
Salicylic acid collodion
Salicylic acid soap
Saligel
Salonil
Stri-dex
trans-Ver-sal
|
|
6 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 4 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
7 |
|
Zinc oxide |
Approved |
Phase 4 |
|
1314-13-2 |
|
Synonyms:
óxido de cinc
oxyde de zinc
Zinc (as oxide)
Zinc (as zinc oxide)
Zinc oxide
|
Zinc óxido
Zinc white
Zinci oxydum
Zincum oxydatum
Zinkoxid
|
|
8 |
|
Iron |
Approved |
Phase 4 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
9 |
|
Oxybenzone |
Approved, Investigational |
Phase 4 |
|
131-57-7 |
4632 |
Synonyms:
(2-Hydroxy-4-methoxyphenyl)phenylmethanone
2-Benzoyl-5-methoxyphenol
2-Hydroxy-4-methoxybenzone
2-Hydroxy-4-methoxybenzophenone
4-Methoxy-2-hydroxybenzophenone
4-Methoxy-2-hydroxybenzophenone butyric acid
Benzophenone-3
Eusolex 4360
|
Eusolex-4360
HMBP CPD
Oxibenzona
OXYBENZONE
Oxybenzonum
Solbar
Uvinul 40
UVINUL M40
|
|
10 |
|
Avobenzone |
Approved, Investigational |
Phase 4 |
|
70356-09-1 |
|
Synonyms:
4-Tert-butyl-4'-methoxydibenzoylmethane
Avobenzone
BMDBM CPD
Butyl methoxydibenzoylmethane
|
Butyl-methoxydibenzoylmethane
Parsol 1789
Parsol-1789
|
|
11 |
|
Titanium dioxide |
Approved |
Phase 4 |
|
13463-67-7 |
|
Synonyms:
dióxido de titanio
óxido de titanio(4)
|
|
|
12 |
|
Metformin |
Approved |
Phase 4 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
13 |
|
Hydroquinone |
Approved, Investigational |
Phase 4 |
|
123-31-9 |
785 |
Synonyms:
1,4-Benzenediol
1,4-Benzoquinol
1,4-Dihydroxy-benzeen
1,4-Dihydroxybenzen
1,4-Dihydroxybenzene
1,4-Dihydroxy-benzol
1,4-Diidrobenzene
1,4-p-Benzenediol
1,4-Phenylenediol
4-Hydroxyphenol
a-Hydroquinone
alpha-Hydroquinone
Artra
Benzene-1,4-diol
Benzohydroquinone
Benzoquinol
beta-Quinol
Black and white
BLACK AND WHITE BLEACHING CREAM
b-Quinol
CHEMBL537
Dihydroquinone
Dihydroxybenzene
Eldopaque
Eldopaque forte
Eldoquin
Eldoquin forte
Esoterica
Hidroquilaude
Hidroquin
Hidroquinona isdin
Hydrochinon
Hydrochinone
Hydroquinol
Hydroquinole
HYDROQUINONE
Hydroquinone for synthesis
Hydroquinone GR
|
Hydroquinone, copper (1+) salt
Hydroquinone, lead (2+) salt (2:1)
Hydroquinone, monocopper (2+) salt
Hydroquinoue
ICN brand 1 OF hydroquinone
ICN brand 2 OF hydroquinone
ICN brand 3 OF hydroquinone
ICN brand 4 OF hydroquinone
Idrochinone
Licostrata
Lustra
Melanasa
Melanex
Melpaque
Melquin
NCI-C55834
Neostrata HQ
NSC-9247
p-Benzenediol
p-Dihydroquinone
p-Dihydroxybenzene
P-Dioxobenzene
p-Dioxybenzene
Phiaquin
p-Hydroquinone
P-Hydroxybenzene
p-Hydroxyphenol
Plough brand 1 OF hydroquinone
Plough brand 2 OF hydroquinone
p-Phenylenediol
p-Quinol
Quinol
Solaquin
Solaquin forte
Stratus brand 1 OF hydroquinone
Stratus brand 2 OF hydroquinone
Ultraquin
|
|
14 |
|
Fluocinolone acetonide |
Approved, Investigational, Vet_approved |
Phase 4 |
|
67-73-2 |
6215 |
Synonyms:
6alpha,9alpha-difluoro-16alpha-hydroxyprednisolone 16,17-acetonide
6alpha-fluorotriamcinolone acetonide
6α,9α-difluoro-16α-hydroxyprednisolone 16,17-acetonide
6α-fluorotriamcinolone acetonide
acétonide de fluocinolone
acetónido de fluocinolona
CAPEX
Capex®|Iluvien®|Synalar®
DERMA-SMOOTHE/FS
DERMOTIC
FLUOCET
fluocinolon acetonid
FLUOCINOLONE
fluocinolone 16,17-acetonide
Fluocinolone acetonide
|
fluocinoloni acetonidum
FLUONID
FLUOTREX
FS SHAMPOO
ILUVIEN
NSC-92339
RETISERT
SYNALAR
SYNALAR FTE
SYNALAR-C
SYNALAR-HP
SYNALAR-N
SYNANDONE
YUTIQ
|
|
15 |
|
Isotretinoin |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
302-79-4, 4759-48-2 |
5538 444795 5282379 |
Synonyms:
(13-cis)-Retinoate
(13-CIS)-RETINOIC ACID
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)NONA-2,4,6,8-TETRAENOIC ACID
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENOIC ACID
(7E,9E,11E,13Z)-Retinoate
(7E,9E,11E,13Z)-RETINOIC ACID
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
13 cis Retinoic acid
13 CIS-RETINOIC ACID
13-cis-Retinoate
13-cis-Retinoate,isotretinoin
13-CIS-RETINOIC ACID
13-CIS-VITAMIN A ACID
13-RA
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoate (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
Aberel
ABSORICA
ACCUTANE
Acid, all-trans-retinoic
Acid, beta-all-trans-retinoic
Acid, retinoic
Acid, trans-retinoic
Acid, vitamin a
Acide retinoique
ACIDE RETINOIQUE (FRENCH)
ACIDE RETINOIQUE (FRENCH) (DSL)
ACTICIN
AGN 100335
Airol
Aknefug
Aknoten
all trans Retinoic acid
all trans-Retinoic acid
all-(e)-Retinoate
all-(e)-Retinoic acid
all-trans-beta-Retinoate
all-trans-beta-Retinoic acid
all-trans-b-Retinoate
all-trans-b-Retinoic acid
all-trans-Retinoate
all-trans-Retinoic acid
ALL-TRANS-RETINOIC ACID (ATRA)
all-trans-retinoic acid (ATRA)|Altreno® (0.05% lotion)|Avita® (0.025% gel)|Renova® (0.02% cream)
all-trans-Tretinoin
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-Β-retinoate
all-trans-Β-retinoic acid
ALTRENO
AMNESTEEM
ATRA
Atra-IV
Atralin
Avita
beta all trans Retinoic acid
beta-all-trans-Retinoic acid
beta-Retinoate
beta-Retinoic acid
b-Retinoate
b-Retinoic acid
CIP-isotretinoin
CIS-RA
cis-Retinoate
|
CIS-RETINOIC ACID
CLARAVIS
Dermairol
Eudyna
ISOTRETINOIN
Isotretinoin zinc salt, 13 cis isomer
Isotretinoin zinc salt, 13-cis-isomer
Isotretinoina
Isotretinoína
Isotretinoine
Isotrétinoine
Isotretinoino
Isotretinoinum
ISOTREX
Lsotretinoin
MYORISAN
NEOVITAMIN A ACID
NSC-122758
PAT-001
Potassium salt, tretinoin
Renova
Retin a
Retin-a
Retin-a micro
RETIN-A-MICRO
Retinoate
Retinoic acid
RETINOIC ACID 13-CIS-FORM
Retionic acid
Retisol-a
Ro 1-5488
RO-43780
RO-4-3780
Roaccutan
ROACCUTANE
Roacutan
Salt, tretinoin potassium
Salt, tretinoin sodium
Salt, tretinoin zinc
Sodium salt, tretinoin
Solage
SOTRET
Stieva-a
Stieva-a Forte
Teriosal
trans Retinoic acid
trans-Retinoate
trans-Retinoic acid
Tretin m
Tretinoin
Tretinoin potassium salt
Tretinoin sodium salt
Tretinoin zinc salt
TRETINOIN、ATRA
Tretinoina
Trétinoïne
TRETINOINE (FRENCH)
TRETINOINE (FRENCH) (EINECS)
Tretinoinum
Tretin-X
Tri-Luma
Vesanoid
Vitamin a acid
Vitinoin
ZENATANE
Zinc salt, tretinoin
Β-retinoate
Β-retinoic acid
|
|
16 |
|
Benzophenone |
Experimental |
Phase 4 |
|
119-61-9 |
3102 |
Synonyms:
1DZP
Adjutan 6016
ADK stab 1413
alpha -Oxodiphenylmethane
alpha -Oxoditane
alpha-Oxodiphenylmethane
alpha-Oxoditane
a-Oxodiphenylmethane
a-Oxoditane
Benzopheneone
BENZOPHENONE
BENZOPHENONE (8ci)
Benzophenone (diphenyl-ketone)
Benzoylbenzene
Benzoyl-benzene
BZQ
|
Di(phenyl)methanone
Diphenyl ketone
Diphenylketone
Diphenyl-methanon
Diphenyl-methanone
DIPHENYLMETHANONE
Diphenylmethanone, 9ci
FEMA 2134
Kayacure BP
Ketone, diphenyl
METHANONE, diphenyl- (9ci)
PH2CO
Phenyl ketone
Α-oxodiphenylmethane
Α-oxoditane
|
|
17 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
18 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 4 |
|
|
|
19 |
|
Keratolytic Agents |
|
Phase 4 |
|
|
|
20 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
21 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
22 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
23 |
|
Antifungal Agents |
|
Phase 4 |
|
|
|
24 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
25 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
26 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
27 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
28 |
|
Analgesics |
|
Phase 4 |
|
|
|
29 |
|
Salicylates |
|
Phase 4 |
|
|
|
Synonyms:
2-Hydroxybenzoate ion(1-)
2-Hydroxybenzoic acid ion(1-)
O-Hydroxybenzoate
|
O-Hydroxybenzoic acid
sal
Salicylic acid
|
|
30 |
|
Photosensitizing Agents |
|
Phase 4 |
|
|
|
31 |
|
Octylmethoxycinnamate |
|
Phase 4 |
|
|
|
32 |
|
Terephthalylidene dicamphor sulfonic acid |
|
Phase 4 |
|
|
|
33 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
34 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
35 |
|
Silymarin |
|
Phase 4 |
|
|
|
36 |
|
Antioxidants |
|
Phase 4 |
|
|
|
37 |
|
Protective Agents |
|
Phase 4 |
|
|
|
38 |
|
Sunscreening Agents |
|
Phase 4 |
|
|
|
39 |
|
Tin Fluorides |
|
Phase 4 |
|
|
|
40 |
|
Radiation-Protective Agents |
|
Phase 4 |
|
|
|
41 |
|
glucocorticoids |
|
Phase 4 |
|
|
|
42 |
|
Coal tar |
Approved |
Phase 3 |
|
8007-45-2 |
|
Synonyms:
|
43 |
|
Selenium |
Approved, Investigational, Vet_approved |
Phase 3 |
|
7783-07-5, 7782-49-2 |
533 |
Synonyms:
[SeH2]
Dihydrogen monoselenide
Dihydrogen selenide
H2Se
Hydrogen selenide, 75Se-labeled
Hydroselenate
Hydroselenic acid
Se(2+)
Se2+
Selane
Selanediide
Selen
|
Selenide
Selenide(2-)
Selenio
Sélénium
Selenium dication
Selenium dihydride
Selenium elemental
Selenium hydride
Selenium hydride (seh2)
Selenium ion (se2+)
Selenium metallicum
Selenium, elemental
|
|
44 |
|
Selenious acid |
Approved, Investigational |
Phase 3 |
|
14124-67-5, 7783-00-8 |
1091 |
Synonyms:
[seo(OH)2]
Acid, selenious
Acid, selenous
Selenige saeure
|
selenige Säure
Selenious acid
Selenite
Selenous acid
|
|
45 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
124-94-7 |
31307 |
Synonyms:
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11Β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
9a-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9a-Fluoro-11b,16a,17a,21-tetrahydroxypregna-1,4-diene-3,20-dione
9a-Fluoro-16a-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-16α-hydroxyprednisolone
Adcortyl
Aristocort
ARISTOCORT A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Celeste
Cinolone
Cinolone-T
DELPHICORT
Fluoxiprednisolone
fluoxiprednisolone|Kenalog®|Nasacort®
Fluoxyprednisolone
Flutex
Fougera
Kenacort
Kenacort-A
Kenacort-Ag
KENALOG
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
|
NASACORT
Nasacort Aq
Nasacort Hfa
NSC-13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Rodinolone
Sk-Triamcinolone
TIAMCINOLONUM
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
TRIAMCINOLONE
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
Vetalog
Volon
Volon A
|
|
46 |
|
Anticoagulants |
|
Phase 3 |
|
|
|
47 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
48 |
|
Trace Elements |
|
Phase 3 |
|
|
|
49 |
|
Sodium Selenite |
|
Phase 3 |
|
|
|
Synonyms:
|
50 |
|
Micronutrients |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 86)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma |
Unknown status |
NCT00927771 |
Phase 4 |
azelaic acid gel;hydroquinone cream |
2 |
Comparing Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment |
Unknown status |
NCT03899233 |
Phase 4 |
Tranexamic acid intradermal microinjections |
3 |
The Efficacy of Oral Tranexamic Acid and a 1927 nm Diode Laser in Patients With Melasma. A Prospective Randomized Split Face Study |
Unknown status |
NCT03686787 |
Phase 4 |
Tranexamic Acid |
4 |
Different Dermatological Approaches in Treatment of Melasma: A Split Face Randomized Clinical Trial |
Unknown status |
NCT03923062 |
Phase 4 |
|
5 |
The Efficacy of Combined Peels in Treatment of Melasma Using Modified Jessner's Solution With 20%Trichloroacetic Acid Versus 70%Glycolic Acid With 20% Trichloroacetic Acid : A Split-face Study |
Unknown status |
NCT03153852 |
Phase 4 |
Modified Jessner's solution;Glycolic acid;Trichloroacetic acid |
6 |
Double Blind Randomized Study of 2% Miconazol Versus 4% Hydroquinone in the Treatment for Melasma. |
Unknown status |
NCT01661556 |
Phase 4 |
Miconazole;Hydroquinone |
7 |
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System |
Completed |
NCT02138539 |
Phase 4 |
Hydroquinone |
8 |
A Double Blind Randomized Study Comparing the Ultraviolet (UV) Photoprotection With UV Plus Visible Light Photoprotection in the Treatment of Melasma. |
Completed |
NCT01695356 |
Phase 4 |
290-400 nm sunscreen;290-800 nm sunscreen |
9 |
Open Label Study to Evaluate the Efficacy and Safety of Sequential Therapy With Fluocinolone Acetonide 0.01%, Hydroquinone (HQ) 4% and Tretinoin 0.05% (TriLuma® Cream) and a Series of Glycolic Acid Peels for the Treatment of Melasma |
Completed |
NCT00472966 |
Phase 4 |
Fluocinolone acetonide 0.1%/hydroquinone 4%/tretinoin 0.05% Cream in sequence with glycolic acid peels |
10 |
An Assessment of the Atrophogenic Potential of Triple Combination Cream Using Histology Measures in the Treatment of Moderate to Severe Melasma |
Completed |
NCT00469183 |
Phase 4 |
Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05% |
11 |
Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma |
Completed |
NCT00500162 |
Phase 4 |
|
12 |
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy |
Completed |
NCT00166192 |
Phase 4 |
|
13 |
The Efficacy of Salicylic Acid Peels Combined With 4% Hydroquinone Cream Versus 4% Hydroquinone Cream Alone in the Treatment of Hispanic Women With Moderate to Severe Melasma |
Completed |
NCT00616239 |
Phase 4 |
20-30% Salicylic Acid peels to the right side of the face;20-30% Salicylic Acid peels to the left side of the face |
14 |
THE METFORMIN AND TRICHLOROACETIC ACID IN TREATMENT OF MELASMA |
Recruiting |
NCT03475524 |
Phase 4 |
MetFORMIN 1000 Mg Oral Tablet;Placebos;Trichloroacetic Acid Peeling;MetFORMIN 500 Mg Oral Tablet |
15 |
Trichloroacetic Acid (TCA) Combined With Microdermabrasion in Treatment of Melasma |
Not yet recruiting |
NCT04823520 |
Phase 4 |
TCA |
16 |
Topical Silymarin Versus Combined Topical Silymarin and Microneedling in Treatment of Melasma: Split Face Study |
Not yet recruiting |
NCT05099601 |
Phase 4 |
|
17 |
Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser; a Comparative Prospective Study |
Terminated |
NCT00863278 |
Phase 4 |
Kligman's Trio |
18 |
Split-Face, Randomized, Open-Label Study of Sequential Treatment With Tri-Luma® Cream With Intense Pulsed Light (IPL) vs. a Mild Inactive Control Cream With Intense Pulsed Light (IPL) in Subjects With Melasma |
Terminated |
NCT00669071 |
Phase 4 |
Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%;Cetaphil® Moisturizing Cream as Inactive Control |
19 |
Oral and 5% Topical Tranexamic Acid in Monotherapy Compared With 4% Topical Hydroquinone for the Treatment of Melasma: Three-arm Randomized, Double-blinded Clinical Trial |
Unknown status |
NCT03585179 |
Phase 3 |
Oral Tranexamic Acid;5% topical tranexamic acid;4% hydroquinone |
20 |
Evaluation of Fractional CO2 Laser and Tranexamic Acid in Treatment of Melasma:Clinical,Histopathological and Immunohistochemical Study |
Unknown status |
NCT04599205 |
Phase 2, Phase 3 |
Tranexamic acid |
21 |
Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma - An Open Randomized, Controlled, Prospective, Single Blinded Clinical Trial |
Unknown status |
NCT00848458 |
Phase 2, Phase 3 |
|
22 |
Evaluation of the Therapeutic Effect of Platelet Rich Plasma in Melasma |
Unknown status |
NCT03308370 |
Phase 3 |
|
23 |
Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial |
Completed |
NCT01442727 |
Phase 3 |
sodium selenite;placebo |
24 |
Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma; a Split Face Study in Tertiary Care Hospital of Karachi |
Completed |
NCT04170088 |
Phase 2, Phase 3 |
Tranexamic Acid;0.9% Normal Saline |
25 |
Randomized, Controlled, Double-blind Study of Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma |
Completed |
NCT03751163 |
Phase 3 |
Tranexamic Acid Oral Product;Hydroquinone 4% Cream |
26 |
Efficacy and Safety of a 4% Hydroquinone Cream (Melanoderm 4%) for the Treatment of Melasma: a Randomized Controlled Split-face Study |
Completed |
NCT02095990 |
Phase 3 |
Hydroquinone;Placebo |
27 |
Efficacy of Melanil in the Treatment of Melasma |
Completed |
NCT01001624 |
Phase 3 |
|
28 |
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In The Treatment Of Facial Melasma, Taking As Reference The Product Triluma ® (Hidroquinone, Fluoncinolone And Tretinoin). |
Suspended |
NCT00717652 |
Phase 2, Phase 3 |
arbutin, tretinoin, triamcinolone;Triluma |
29 |
Efficacy of Platelet-rich Plasma in Treatment of Melasma |
Completed |
NCT03674203 |
Phase 2 |
|
30 |
An Open-Label Pilot Study Evaluating the Effectiveness and Tolerability of a Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma |
Completed |
NCT02730819 |
Phase 2 |
Illuminate Cream |
31 |
A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma |
Completed |
NCT03049059 |
Phase 2 |
4% hydroquinone cream |
32 |
Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma |
Completed |
NCT03982849 |
Phase 2 |
Hydroquinone 4% Cream;silymarin 0.7% cream |
33 |
Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma: a Double Blind Prospective Randomzed Study |
Recruiting |
NCT05119413 |
Phase 2 |
New trio de Kligman;Trio Kligman |
34 |
Comparative Study for the Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser (532nm) |
Unknown status |
NCT03885895 |
Phase 1 |
Tranexamic Acid Injectable Product |
35 |
Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma |
Completed |
NCT04346901 |
Phase 1 |
Thiamazol |
36 |
Comparative Study Between Chemical Peeling With 70% Glycolic Acid and Intradermal Transamine for the Treatment of Melasma. |
Completed |
NCT05362500 |
Phase 1 |
Glycolic Acid 70%;Tranexamic acid injection |
37 |
Green Banana Peel Extract for Melasma Treatment |
Completed |
NCT05031689 |
Phase 1 |
|
38 |
Spironolactone for the Treatment of Melasma: a Prospective, Open-label Proof-of-concept and Dose-ranging Study |
Withdrawn |
NCT03953209 |
Phase 1 |
Spironolactone 50Mg Tablet;Spironolactone 100Mg Tablet;Spironolactone 200Mg |
39 |
Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma |
Withdrawn |
NCT02892071 |
Phase 1 |
22% TCA peel |
40 |
The Efficacy of Melanostop Peel in Combination With Specifically Selected Home Care Regimen for Improvement of Melasma |
Unknown status |
NCT03826277 |
|
|
41 |
A Prospective, Double-blind, Split-body, Randomized Controlled Trial to Assess the Efficacy of Low Level Laser Therapy for Pigmentary Disorders |
Unknown status |
NCT04308421 |
|
|
42 |
Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial |
Unknown status |
NCT04597203 |
|
topical 2% hydroquinone |
43 |
A Split-face Comparison of Low Fluence 1064-nm Q-switched Nd:YAG Laser Plus Vitamin C vs Low Fluence 1064-nm Q-switched Nd:YAG Laser Plus Intradermal Tranexamic Acid Injection for Melasma:a Single Blinded, Randomised Study |
Unknown status |
NCT03008655 |
|
|
44 |
Evaluation of the Lutronic PicoPlus for the Treatment of Dematological Conditions Such as Unwanted Tattoos and Benign Pigmented Lesions |
Unknown status |
NCT03415685 |
|
|
45 |
Combined Trichlotoaceticacid and Microneedle Versus Trichlroacetic Acid Alone in the Treatment of Melasma |
Unknown status |
NCT03472235 |
|
|
46 |
Evaluation of the Lutronic LaseMD System for the Treatment of Melasma |
Unknown status |
NCT03456674 |
|
|
47 |
A Pilot Study Comparing the Efficacy of 1064 Q-switch Laser vs. Glycolic Acid Peels for the Treatment of Melasma: A Randomized Control Trial |
Completed |
NCT01976273 |
|
|
48 |
Comparative Study of Dual Yellow Laser Versus Stabilized Kilnman Preparation in the Treatment of Melasma |
Completed |
NCT01850186 |
|
Stabilized kilnman trio |
49 |
Study of the Influence of Blue Light Emitted by Computer / Television Screens on Melasma Single-center, Interventional, Randomized, Single-blind Study (Masked Investigator) MELABLUE Study |
Completed |
NCT03877445 |
|
|
50 |
Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity. A Prospective Randomized Placebo-controlled Study |
Completed |
NCT03878433 |
|
Glisodin |
|